Lower Austria Latest News (Austria)

Real-life study on "Terror Management Theory" in the war zone of Ukraine. Karl Landsteiner University of Health Sciences shows effects of war on mental health, somatic symptoms and well-being.

Karl Landsteiner University of Health Sciences important study center. Data published in New England Journal of Medicine.

Worldwide satellite data analyzed, structured and published by Karl Landsteiner University of Health Sciences, Austria

Research Team at the Karl Landsteiner University of Health Sciences develops novel protocol for studying isolated pairs of hippocampal neurons. Dedicated work honoured by cover page in Bio-protocol Journal.

Austrian Center for Ion Therapy (MedAustron) Demonstrates Excellent Control of Small-to-Mid Sized Tumors of Chordoma.

KL Krems, Harvard Medical School and Johns Hopkins University find striking volume changes in special structures of the auditory apparatus

Animal Free 3D Bioprinting: 'Human Inks' to 3D Printing Human Tissues: HU3DINKS Project Brings Together Expert Companies for the Development of Human Tissue-based Inks.

What are Viarecta Male Enhancement? Viarecta Male Enhancement pills are profoundly enjoyable edibles that give countless human medical advantages and are inconceivably helpful for the turn of events and generally speaking development of a human body.

For those affected by B-cell cancer, a third SARS-CoV-2 vaccination is of particular importance.

Scientist at IMC Krems develops machine learning-based software to simulate future car crash scenarios

The distinction between primary tumors and metastases can be made quickly and accurately in brain tumors using radiomics and deep learning algorithms.

Scientist of the Institute Krems Bioanalytics at IMC Krems uses chemoproteomics to discover the scaffold protein NUBP2 as a promising candidate.

Study by Karl Landsteiner University of Health Sciences shows need for timely consultations for palliative care in small cell lung cancer.

Research results from Institute Krems Bioanalytics of IMC Krems and Takeda will help to treat patients suffering from hemophilia A more effectively.

A team from the Karl Landsteiner University in Krems, Austria, finds a high redundancy in proteins that modulate neuronal networks and neuronal signal transmission

For the first time, type, cause and outcome caused by penetrating objects recorded. Study of the Karl Landsteiner University of Health Sciences Krems.

Plant-derived ring peptide and its variants show anti-tumor activity against lymphoma cells. Oncological study with participation of KL Krems.

Benefits of surgery support by proven drug demonstrated at Karl Landsteiner University of Health Sciences

International & interdisciplinary: conference on digital transformation in nursing presents results. KL Krems Co-editor.

European University E³UDRES² Extends Entrepreneurship & Innovation Network

Study by Karl Landsteiner University for Health Sciences demonstrates partial superiority of artificial intelligence and physiological image data in brain tumor classification

An international team led by a physician from the Karl Landsteiner University for Health Sciences, Krems, describes for the first time a mutation of the IL-33 gene in the human genome that results in multiple manifestations

European University E³UDRES² Expands Consortium and Successfully Strengthens Collaborations

Karl Landsteiner University of Health Sciences in Krems (Austria) investigates recovery time after reconstructive breast surgery of breast cancer patients

Clinical researchers at Karl Landsteiner University Krems (Austria) evaluate novel diagnostic technique prospectively for the first time in Europe

Simplified calculation model for tissue properties developed at Karl Landsteiner University for Health Sciences Krems (Austria).

The European University E³UDRES² presents new education model

Thanks to a team from Karl Landsteiner University of Health Sciences in Krems (Austria), standardised classification of the aggressiveness of tumours based on their shape is now possible.